Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2025-12-25 @ 8:05 PM
Study NCT ID:
NCT01110135
Status:
COMPLETED
Last Update Posted:
2017-05-24
First Post:
2010-04-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08
Start Date Type:
None
Primary Completion Date:
2013-11
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2010-04-20
First Submit QC Date:
None
Study First Post Date:
2010-04-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-14
Results First Submit QC Date:
None
Results First Post Date:
2017-05-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-14
Last Update Post Date:
2017-05-24
Last Update Post Date Type:
ACTUAL